← All trials
NCT03674606
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2014
- Primary completion
- Apr 13, 2016
- Completion date
- Apr 13, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 546
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National University of IrelandLead sponsor
- Royal College of Surgeons, IrelandCollaborator
- National Maternity Hospital, IrelandCollaborator
- Perinatal IrelandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.